Published October, 2012
By Wim B. van den Berg and Pierre Miossec
Publisher: Springer (Birkhauser Verlag AG)
Series: Progress in Inflammation Research
Rating: 0.00
Availability: Available

The purpose of this volume in the Progress in Inflammation Research series is to provide the biomedical and clinical researcher with a state-of-the-art insight in the role of cytokines in joint inflammation and joint destruction.

---

Published October, 2012
By Douglas W. Morgan, Ulf J. Forssman and Marian T. Nakada
Publisher: Springer (Birkhauser Verlag AG)
Series: Progress in Inflammation Research
Rating: 0.00
Availability: Available

Such coverage, as presented in this volume, may help further understanding and bring new approaches to therapeutics.The first section of the book discusses inflammatory mechanisms, studied in cellular and animal studies.

---

Published October, 2012
By Johan Zaagsma, Herman Meurs and Ad F. Roffel
Publisher: Springer (Birkhauser Verlag AG)
Series: Progress in Inflammation Research
Rating: 0.00
Availability: Available

---

Published October, 2012
By Raymond G Hill, Dalip J.S. Sirinathsinghji and Ray G. Hill
Publisher: Springer (Birkhauser Verlag AG)
Series: Progress in Inflammation Research
Rating: 0.00
Availability: Available

---

Published October, 2012
By Peter J. Barnes and Trevor T. Hansel
Publisher: Springer (Birkhauser Verlag AG)
Series: Progress in Inflammation Research
Rating: 0.00
Availability: Available

Chronic obstructive pulmonary disease (COPD) ranges amongst the commonest diseases in the world. The relentless progression of the disease causes a pressing need for a better understanding of and therapies for COPD. This volume provides state-of-the-art information on the pathophysiology of COPD including an outlook on new therapies.

---

Published October, 2012
By Bengt Samuelsson, Giancarlo Folco and Robert C. Murphy
Publisher: Springer (Birkhauser Verlag AG)
Series: Progress in Inflammation Research
Rating: 0.00
Availability: Available

Many new antileukotriene drugs are now marketed as antiasthma drugs and represent the first new drugs in this field since the 1970s.

---

Published October, 2012
By Satwant K. Narula and Robert Coffman
Publisher: Springer (Birkhauser Verlag AG)
Series: Progress in Inflammation Research
Rating: 0.00
Availability: Available

Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics.

---

Published October, 2012
By Cees G.M. Kallenberg and Jan W. Cohen Tervaert
Publisher: Springer (Birkhauser Verlag AG)
Series: Progress in Inflammation Research
Rating: 0.00
Availability: Available

Especially the past two decades have seen renewed interest in the vasculitides. Drawing from their work in rheumatology, nephrology, internal medicine, connective tissue disease and clinical immunology, they present new concepts in classificiation, diagnosis and pathophysiology of the vasculitides.

---

Published October, 2012
By Alfred N. Fonteh and Robert L. Wykle
Publisher: Springer (Birkhauser Verlag AG)
Series: Progress in Inflammation Research
Rating: 0.00
Availability: Available

---

Published October, 2012
By Annika B. Malmberg and Sandra R. Chaplan
Publisher: Springer (Birkhauser Verlag AG)
Series: Progress in Inflammation Research
Rating: 0.00
Availability: Available

Numerous improvements in our understanding of the mechanisms that underlie neuropathic pain states have come from the development of animal models, most of which involve partial peripheral nerve injury.

---